Clinical Care Pathway for the Risk Stratification and Management of Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

An updated clinical care pathway improves screening, diagnosis, and management of MASLD/MASH, guiding clinicians through a standardized approach for metabolic liver disease.

• Why it matters: Effective risk stratification and treatment of MASLD/MASH are crucial due to rising prevalence and associated health complications, yet standardized guidance has been lacking.
• What they did: A multidisciplinary team developed an evidence-based clinical care pathway and a mobile application, incorporating the latest diagnostic and treatment strategies for MASLD/MASH.
• The result: This comprehensive approach enhances clinical decision-making and patient care, facilitating early detection and tailored management of metabolic liver disease.